852180-47-3

Basic information

• Product Name: TERT-BUTYL 4-[4-(AMINOMETHYL)PHENYL]TETRAHYDRO-1(2H)-PYRAZINECARBOXYLATE
• Synonyms: N1-BOC-4-(AMINOMETHYL)PHENYLPIPERAZINE;tert-Butyl 4-[4-(aminomethyl)phenyl]piperazine-1-carboxylate, 4-[4-(tert-Butoxycarbonyl)piperazin-1-yl]benzylamine;tert-Butyl 4-(4-(aMinoMethyl)phenyl)piperazine-1-carboxylate;4-(4-Aminomethylphenyl)piperazine-1-carboxylic acid tert-butyl ester;4-[(Aminomethyl)phenyl]piperazine,N1-BOCprotected90%;4-(AMINOMETHYL)PHENYLPIPERAZINE, N1-BOC PROTECTED;1-BOC-4-(4-AMINOMETHYL-PHENYL)-PIPERAZINE;1-(4-AMINOMETHYL-PHENYL)-PIPERAZINE-4-CARBOXYLIC ACID TERT-BUTYL ESTER
• CAS NO: 852180-47-3
• Molecular Formula: C₁₆H₂₅N₃O₂
• Molecular Weight: 291.39
• Mol File: 852180-47-3.mol
• Article Data: 4

Chemical Properties

• Melting Point: 95-96°C
• Boiling Point: 441°C at 760 mmHg
• Flash Point: 220.5°C
• Appearance: /
• Density: 1.121g/cm³
• Vapor Pressure: 5.62E-08mmHg at 25°C
• Refractive Index: 1.553
• PKA: 10.40±0.10(Predicted)
• CAS DataBase Reference: TERT-BUTYL 4-[4-(AMINOMETHYL)PHENYL]TETRAHYDRO-1(2H)-PYRAZINECARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: TERT-BUTYL 4-[4-(AMINOMETHYL)PHENYL]TETRAHYDRO-1(2H)-PYRAZINECARBOXYLATE(852180-47-3)
• EPA Substance Registry System: TERT-BUTYL 4-[4-(AMINOMETHYL)PHENYL]TETRAHYDRO-1(2H)-PYRAZINECARBOXYLATE(852180-47-3)

Safety Data

• Hazard Codes: T
• Statements: 36/37/38-25
• Safety Statements: 26-36/37/39-45
• HazardClass: IRRITANT
• Hazardous Substances Data: 852180-47-3(Hazardous Substances Data)

Usage

General Description

TERT-BUTYL 4-[4-(AMINOMETHYL)PHENYL]TETRAHYDRO-1(2H)-PYRAZINECARBOXYLATE is a chemical compound with a complex structure. It consists of a tert-butyl group attached to a tetrahydropyrazine ring, which in turn is substituted with a carboxylate group and a 4-(aminomethyl)phenyl group. TERT-BUTYL 4-[4-(AMINOMETHYL)PHENYL]TETRAHYDRO-1(2H)-PYRAZINECARBOXYLATE is often used in the field of organic synthesis and pharmaceutical research, where it can be employed as a building block in the creation of various pharmaceutical drugs and biologically active molecules. Its structure suggests that it may have potential applications as a drug candidate or a precursor for the synthesis of pharmaceutical compounds due to its unique pharmacophore. However, further research is needed to fully understand its potential uses and effects.

InChI:InChI=1/C16H25N3O2/c1-16(2,3)21-15(20)19-10-8-18(9-11-19)14-6-4-13(12-17)5-7-14/h4-7H,8-12,17H2,1-3H3

Upstream product

• 623-00-7 4-bromobenzenecarbonitrile 
• 57260-71-6 1-t-Butoxycarbonylpiperazine 
• 1194-02-1 4-fluorobenzonitrile 
• 186650-98-6 tert-butyl 4-(4-cyanophenyl)piperazine-1-carboxylate 

Downstream Products

• 1149380-80-2 1,1-dimethylethyl 4-(4-{[({6-[3-endo-({[2-methyl-3-(methyloxy)phenyl]carbonyl}amino)-8-azabicyclo[3.2.1]oct-8-yl]pyridine-3-yl}carbonyl)amino]methyl}phenyl)piperazine-1-carboxylate 
• 1033693-69-4 tert-butyl 4-{4-[(3-isobutyl-2,5-dioxo-2,3-dihydroimidazo[2,1-b]quinazolin-1(5H)-yl)methyl]phenyl}piperazine-1-carboxylate 
• 1403940-97-5 6-chloro-2-ethyl-N-(4-(4-(4-fluorobenzoyl)piperazin-1-yl)benzyl)imidazo[1,2-a]pyridine-3-carboxamide 
• 1349745-15-8 tert-butyl 4-(4-((2-chloro-5-methoxy-4-nitrophenethylamino)methyl)phenyl)piperazine-1-carboxylate 
• 1038388-18-9 C₃₁H₃₅N₅O₅S 
• 831203-80-6 5-nitro-furan-2-carboxylic acid 4-piperazin-1-yl-benzylamide 
• 831203-79-3 4-(4-{[(5-nitro-furan-2-carbonyl)-amino]-methyl}-phenyl)-piperzine-1-carboxylic acid ter-butyl ester 

Relevant articles and documents

Benzoquinone derivative, pharmaceutical composition, and applications thereof

The invention discloses a benzoquinone derivative, a pharmaceutical composition, and applications thereof. According to the invention, the benzoquinone derivative (I), and the stereoisomer or the pharmaceutically acceptable salt thereof possess a structure disclosed in the invention. The benzoquinone derivative possesses excellent inhibition effect on STAT3 level both in vivo and in vitro, and further, the benzoquinone derivative is capable of inhibiting balling capacity of cancer cells.

ANTI-INFECTIVE COMPOUNDS

The present invention relates to small molecule compounds and their use in the treatment of bacterial infections, in particular Tuberculosis.